HeartSciences Inc HSCS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
HeartSciences Shareholders Approve Proposed Business Combination with Fortitude Mining
Fortitude Announces 15 MW Aurora, Nebraska Facility Now Participating in Southwest Power Pool Markets
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
Fortitude Secures Priority Supply Allocation for BITMAIN’s Next-Generation Zcash Mining Equipment, Announces $100 Million Non-Binding Purchase Commitment, and Additional Upsizing of DCG Credit Facility and Available ZEC Funding from DCG
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
Fortitude Announces Amendment to Existing DCG Credit Facility, Increasing Commitment by $24 Million and Providing for Future Funding in ZEC
Fortitude Appoints Jaime Leverton as Chief Executive Officer
Trading Information
- Previous Close Price
- $2.10
- Day Range
- $2.01–2.19
- 52-Week Range
- $1.63–5.25
- Bid/Ask
- $1.99 / $2.03
- Shares Outstanding
- 5.76M
- Market Cap
- $10.09M
- Volume/Avg
- 14,906 / 165,652
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1,494.66
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 14
Valuation
Metric | HSCS |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1,494.66 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | HSCS |
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.14 |
Interest Coverage | −11.75 |
Quick Ratio
HSCS
Profitability
Metric | HSCS |
|---|---|
Return on Assets (Normalized) | −144.59% |
Return on Equity (Normalized) | −513.37% |
Return on Invested Capital (Normalized) | −166.18% |
Return on Assets
HSCS
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|HV^ct> | LOCK|$Z?T | $180B | |||
| Medtronic PLC MDT | LOCK|?>>n&T | LOCK|^P>M | $129B | |||
| Stryker Corp SYK | LOCK|Z@dD&ll | LOCK|xYq | $119B | |||
| Boston Scientific Corp BSX | LOCK|Z!zkmr< | LOCK|>l^B? | $62B | |||
| Edwards Lifesciences Corp EW | LOCK|^ZCCs%d | LOCK|t&rT | $60B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|HHYdBq# | LOCK|Srg | $37B | |||
| DexCom Inc DXCM | LOCK|?J#vR<@< | LOCK|t!zql | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|c> | LOCK|t& | $29B | |||
| Steris PLC STE | LOCK|fml%H^ | LOCK|!G%w | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|!<jl^!^ | LOCK|b# | $19B |